Eliem Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $148k | 74k | 2.01 |
| 2025-03-31 | $147k | 121k | 1.22 |
| 2024-12-31 | $226k | 125k | 1.80 |
| 2024-09-30 | $301k | 59k | 5.09 |
| 2022-06-30 | $492k | 163k | 3.02 |
| 2022-03-31 | $1.4M | 165k | 8.39 |
| 2021-12-31 | $1.7M | 164k | 10.46 |
| 2021-09-30 | $3.0M | 166k | 17.98 |